Tumor-associated macrophage (TAM) infiltration in gastric cancer
- PMID: 14666722
Tumor-associated macrophage (TAM) infiltration in gastric cancer
Abstract
Background: Tumor-associated macrophages (TAMs) are defined as macrophages that migrate into the tumor stroma. TAMs are known to directly or indirectly affect immune suppression. TAMs have not previously been reported in gastric cancer.
Materials and methods: Using anti-CD68 antibodies, we immunohistochemically evaluated TAM infiltration in 97 gastric cancer patients who underwent tumor resection. Furthermore, CD3-zeta chain expression of tumor infiltrating lymphocytes (TILs) from the same section was also examined. According to the degree of TAM infiltration, 97 patients were divided into two groups (high TAM group, more than 200 positive cells; low TAM group, less than 200 positive cells). Clarification of the clinicopathological features of TAM-positive gastric cancer was attempted.
Results: TAM infiltration in the tumor nest ranged from 0 to 621 cells (average 187). The degree of infiltration positively correlated with depth of invasion, nodal status and clinical stage. Patients in the high TAM group had lower CD3-zeta expression by TILs than patients in the low TAM group. CD3-zeta expression by TILs negatively correlated with infiltration of TAMs (p < 0.01). Patients with a high TAM count had poorer surgical outcomes than those with a low TAM count.
Conclusion: From the results of the current study, TAM infiltration may be used as a prognostic marker in gastric cancer. Negative correlation between TAM infiltration and CD3-zeta expression by TILs suggests that TAMs may be responsible for the immunological inactivity of T cells in gastric cancer.
Similar articles
-
The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.Anticancer Res. 2003 Nov-Dec;23(6D):5015-22. Anticancer Res. 2003. PMID: 14981961
-
Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.Anticancer Res. 2005 Jan-Feb;25(1B):463-70. Anticancer Res. 2005. PMID: 15816613
-
Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.Anticancer Res. 2002 Nov-Dec;22(6C):4291-6. Anticancer Res. 2002. PMID: 12553072
-
Pathophysiology of tumor-associated macrophages.Adv Clin Chem. 2008;45:199-223. Adv Clin Chem. 2008. PMID: 18429498 Review.
-
Role of tumour-associated macrophages in cancer-related inflammation.Exp Oncol. 2010 Sep;32(3):153-8. Exp Oncol. 2010. PMID: 21403610 Review.
Cited by
-
Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review.Chronic Dis Transl Med. 2018 Sep 3;4(3):156-163. doi: 10.1016/j.cdtm.2018.07.001. eCollection 2018 Sep. Chronic Dis Transl Med. 2018. PMID: 30276362 Free PMC article.
-
Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.J Cell Mol Med. 2016 Jun;20(6):1024-35. doi: 10.1111/jcmm.12787. Epub 2016 Feb 4. J Cell Mol Med. 2016. PMID: 26843477 Free PMC article.
-
Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent manner.Am J Transl Res. 2019 Sep 15;11(9):6040-6054. eCollection 2019. Am J Transl Res. 2019. PMID: 31632572 Free PMC article.
-
Prognostic significance of preoperative peripheral blood monocyte ratio in patients with hepatocellular carcinoma.World J Surg. 2014 Sep;38(9):2377-85. doi: 10.1007/s00268-014-2545-8. World J Surg. 2014. PMID: 24692003
-
High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression.Oncol Lett. 2018 May;15(5):6217-6224. doi: 10.3892/ol.2018.8119. Epub 2018 Feb 27. Oncol Lett. 2018. PMID: 29616104 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical